Inactive Instrument
Oncternal Therapeutics, Inc. Stock
Stocks
ONCT
US68236P2065
Biotechnology & Medical Research
| 1 day | -24.11% |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Vincent
DFI | Director of Finance/CFO | 63 | 2017-03-31 |
Yisrael Katz
CTO | Chief Tech/Sci/R&D Officer | - | 2023-06-30 |
Rajesh Krishnan
CTO | Chief Tech/Sci/R&D Officer | 53 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Dan Kisner
BRD | Director/Board Member | 79 | 2019-06-06 |
William LaRue
BRD | Director/Board Member | 75 | 2017-11-30 |
Xin Nakanishi
BRD | Director/Board Member | 64 | 2018-10-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/20/24 | Free | Director | 2,200 | 0.0743% | ||
| 6/20/24 | Free | Director | 2,200 | 0.0743% | ||
| 6/20/24 | Free | Director | 2,200 | 0.0743% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -24.11% | -25.83% | - | - | 1.56M | ||
| -2.69% | -0.48% | +53.97% | +66.82% | 66.33B | ||
| +0.27% | +3.19% | +11.18% | +95.78% | 60.62B | ||
| +1.05% | +2.00% | +24.69% | +90.38% | 55.5B | ||
| +0.14% | +2.35% | +13.86% | +111.94% | 47.58B | ||
| -2.21% | -2.47% | +20.18% | +28.81% | 43.69B | ||
| -2.30% | -10.40% | +154.30% | +707.36% | 37.27B | ||
| +2.15% | +1.42% | +14.58% | +48.71% | 36.57B | ||
| +3.09% | -3.17% | +79.45% | +61.43% | 32.22B | ||
| +2.62% | +5.90% | -37.29% | +386.59% | 26.58B | ||
| Average | -2.19% | +0.05% | +37.21% | +177.53% | 45B | |
| Weighted average by Cap. | -0.07% | +0.20% | +36.97% | +153.15% |
Employees
29
















